Company Profile
Revolution Medicines Stock Price, News & Analysis
- Ticker:
- RVMD
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- United States
Why the stock is moving
RVMD is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Revolution Medicines is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Revolution Medicines is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Revolution Medicines follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Revolution Medicines sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Revolution Medicines's catalysts are daraxonrasib in RAS-mutant solid tumors and the rest of its RAS-pathway program, which can re-rate quickly if the data stay clean. The company needs each update to keep proving that the RAS thesis is real.
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
Revolution Medicines Reports First Quarter 2026 Financial Results and Update on Corporate Progress
Source: Revolution Medicines
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Revolution Medicines do?
Revolution Medicines is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Where is Revolution Medicines based and where is the stock listed?
Revolution Medicines is listed on NASDAQ, Headquartered in the United States and listed on NASDAQ, Revolution Medicines is followed within the biotech universe for its exposure to catalyst-driven execution..
On which exchange is RVMD stock listed?
Revolution Medicines (RVMD) is associated with NASDAQ, United States, Biotechnology.
What is Revolution?
Revolution Medicines's catalysts are daraxonrasib in RAS-mutant solid tumors and the rest of its RAS-pathway program, which can re-rate quickly if the data stay clean.
Which conditions is Revolution Medicines targeting with Revolution?
Revolution Medicines's catalysts are daraxonrasib in RAS-mutant solid tumors and the rest of its RAS-pathway program, which can re-rate quickly if the data stay clean.
How does Revolution Medicines describe recent progress with Revolution?
Revolution Medicines's catalysts are daraxonrasib in RAS-mutant solid tumors and the rest of its RAS-pathway program, which can re-rate quickly if the data stay clean.
What is Medicines?
Revolution Medicines is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What should investors watch for with Medicines?
Revolution Medicines's catalysts are daraxonrasib in RAS-mutant solid tumors and the rest of its RAS-pathway program, which can re-rate quickly if the data stay clean.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.